In addition, while tumor P53 mutations are known to lead to TAM accumulation, activation of KRAS signaling leads to PMN-MDSC accumulation, and EGFR mutations lead to Treg cell activation (49–52). The gene discussed is EGFR; the disease is neoplasm.